Enliven Therapeutics shares owned by KBC Group NV
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by KBC Group NV
from 13F filings
Historical chart of KBC Group NV investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by KBC Group NV
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $38k | 958 | 39.67 |